Shuli Xia
- Genetics top 2%
- Glioma Diagnosis and Treatment 10
- Cancer Research top 5%
- MicroRNA in disease regulation 6
- Molecular Biology top 5%
- Epigenetics and DNA Methylation 15
- Kruppel-like factors research 9
- Cancer-related gene regulation 8
- Cell death mechanisms and regulation 5
- Hepatology top 5%
- Liver physiology and pathology 9
- Oncology top 5%
- Cancer Cells and Metastasis 8
- Co-authors
- John LaterraBachchu LalMingyao YingC. Rory GoodwinYingying SangJiang QianSteven M. RothmanShan Yu
- Partner nations
- United StatesChinaGermany
In The Last Decade
Shuli Xia
65 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 108
- Genetics 424
- Cancer Research 497
- Molecular Biology 1.7k
- Hepatology 149
- Oncology 496
Countries citing papers authored by Shuli Xia
This map shows the geographic impact of Shuli Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuli Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuli Xia more than expected).
Fields of papers citing papers by Shuli Xia
This network shows the impact of papers produced by Shuli Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuli Xia. The network helps show where Shuli Xia may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shuli Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 4 | |
| 2 | 2023 | 1 | |
| 3 | 2021 | 16 | |
| 4 | 2021 | 4 | |
| 5 | 2021 | 14 | |
| 6 | 2021 | 12 | |
| 7 | 2021 | 39 | |
| 8 | 2020 | 29 | |
| 9 | 2019 | 60 | |
| 10 | MeDReaders: a database for transcription factors that bind to methylated DNA | 2018 | 1 |
| 11 | 2018 | 111 | |
| 12 | 2016 | 28 | |
| 13 | 2016 | 5 | |
| 14 | 2014 | 44 | |
| 15 | 2012 | 17 | |
| 16 | 2011 | 11 | |
| 17 | 2010 | 43 | |
| 18 | 2009 | 19 | |
| 19 | 2008 | 10 | |
| 20 | A new assay system for the cell growth promoting effects of insulin and growth factors | 1995 | 1 |
About Shuli Xia
Shuli Xia is a scholar working on Hepatology, Genetics, Cancer Research, Molecular Biology and Oncology, having authored 66 papers that have together received 2.6k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (15 papers), Glioma Diagnosis and Treatment (10 papers), Liver physiology and pathology (9 papers), Kruppel-like factors research (9 papers), Cancer Cells and Metastasis (8 papers), Cancer-related gene regulation (8 papers), MicroRNA in disease regulation (6 papers) and Cell death mechanisms and regulation (5 papers). The work is most often cited by research in Genetics (424 citations), Cancer Research (497 citations), Molecular Biology (1.7k citations), Hepatology (149 citations) and Oncology (496 citations). Shuli Xia has collaborated with scholars based in United States, China and Germany. Frequent co-authors include John Laterra, Bachchu Lal, Mingyao Ying, C. Rory Goodwin, Yingying Sang, Jiang Qian, Steven M. Rothman, Shan Yu, Ling Wei and Ai Xiao. Their work appears in journals such as Cancer Research, Molecular Cancer Research, Cancer Letters, BMC Cancer and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.